Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
SAWAI GROUP HOLDINGS Co., Ltd. ( (JP:4887) ) has provided an update.
Sawai Group Holdings Co., Ltd. has completed the repurchase of 1,688,900 of its own shares, amounting to approximately 3.29 billion yen, as part of a strategic decision to enhance shareholder value. This move, approved by the Board of Directors, aligns with their broader repurchase plan, which includes retiring 16,016,600 shares by April 30, 2025, potentially impacting the company’s stock value and market perception.
More about SAWAI GROUP HOLDINGS Co., Ltd.
Sawai Group Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of generic drugs. The company is listed on the Prime Market of the Tokyo Stock Exchange and is known for its commitment to providing affordable medication options.
YTD Price Performance: -5.74%
Average Trading Volume: 674,722
Technical Sentiment Consensus Rating: Sell
Current Market Cap: Yen266.6B
See more data about 4887 stock on TipRanks’ Stock Analysis page.